KRYS – krystal biotech, inc. (US:NASDAQ)

News

Krystal Biotech to Present at TD Cowen 46th Annual Health Care Conference
Krystal Biotech's KB707 RMAT Win Opens New Lung Cancer Chapter [Yahoo! Finance]
Biotech Investor Adds $3 Million to Krystal Biotech as Revenue Hits $389 Million in 2025 [Yahoo! Finance]
Jefferies Raises its Price Target on Krystal Biotech, Inc. (KRYS) to $371 and Maintains a Buy Rating [Yahoo! Finance]
Krystal Biotech (NASDAQ:KRYS) was upgraded by analysts at Weiss Ratings from a "hold (c+)" rating to a "buy (b-)" rating.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com